Education
About Us
Working with TipRanks
Follow Us
Wuhan General Group [china] (WUHN)
:WUHN
WUHN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.01 - $0.01
Previous CloseN/A
Volume1.20K
Average Volume (3M)N/A
Market Cap
$4.81K
Enterprise Value-$18.97K
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$86.79K
Price to Earnings (P/E)―
Beta-20.39
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding48,055,160
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)<0.01
Price to Sales (P/S)0.00
P/FCF Ratio>-0.01
Enterprise Value/Market Cap-3.95
Enterprise Value/Revenue-4.15
Enterprise Value/Gross Profit-9.12
Enterprise Value/Ebitda<0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
WUHN FAQ
What was Wuhan General Group [china]’s price range in the past 12 months?
Wuhan General Group [china] lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
What is Wuhan General Group [china]’s market cap?
Wuhan General Group [china]’s market cap is $4.81K.
When is Wuhan General Group [china]’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Wuhan General Group [china]’s earnings last quarter?
Currently, no data Available
Is Wuhan General Group [china] overvalued?
According to Wall Street analysts Wuhan General Group [china]’s price is currently Overvalued.
Does Wuhan General Group [china] pay dividends?
Wuhan General Group [china] does not currently pay dividends.
What is Wuhan General Group [china]’s EPS estimate?
Wuhan General Group [china]’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Wuhan General Group [china] have?
Wuhan General Group [china] has 48,055,160 shares outstanding.
What happened to Wuhan General Group [china]’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Wuhan General Group [china]?
Currently, no hedge funds are holding shares in WUHN
Company Description
Wuhan General Group [china]
Wuhan General Group (China), Inc., through its subsidiaries, researches, develops, and commercializes a range of cannabidiol (CBD)-based products under the Dr. AnnaRx brand for pharmacies. It also focuses on exploring and developing other indications for psilocybin new therapies that will enable patients who suffer from mental illness. The company offers its products for medical applications, including cancer, mental disorders, chronic pain, and others. Wuhan General Group (China), Inc. is headquartered in Pointe-Claire, Canada.
Biodexa Pharmaceuticals
―
Hepion Pharmaceuticals
―
LogicMark
―
iCoreConnect
―
Sharps Technology, Inc.
―